Scientific Opinion on the substantiation of health claims related to Lactobacillus johnsonii BFE 6128 and “natural defences/immune system” (ID 990) and “skin health” (ID 991) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Tabs

Article
EFSA Journal 2011;9(4):2026 [13 pp.].
doi
10.2903/j.efsa.2011.2026
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Panel Members
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Acknowledgement

The Panel wishes to thank for the preparatory work on this scientific opinion: The members of the Working Group on Claims: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Marina Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen. The members of the Claims Sub-Working Group on Gut/Immune: Jean-Louis Bresson, Maria Carmen Collado, Miguel Gueimonde, Daisy Jonkers, Martinus Løvik, Bevan Moseley, Maria Saarela, Seppo Salminen, Yolanda Sanz, Stephan Strobel, Daniel Tomé and Hendrik van Loveren.

Contact
Type
Opinion of the Scientific Committee/Scientific Panel
On Request From
European Commission
Question Number
EFSA-Q-2008-1767
EFSA-Q-2008-1768
Adopted
12 November 2010
Published
8 April 2011
Affiliation
European Food Safety Authority (EFSA), Parma, Italy
Note
Article (197.14 KB)197.14 KB
Summary

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to Lactobacillus johnsonii BFE 6128 and “natural defences/immune system” and “skin health”. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.

The food constituent that is the subject of the health claims is Lactobacillus johnsonii BFE 6128. The Panel considers that Lactobacillus johnsonii BFE 6128 is sufficiently characterised.

“Natural defences/immune system”

The claimed effect is “natural defences/immune system”. The target population is assumed to be the general population. The claimed effect is not sufficiently defined and no further details were given in the proposed wording or the clarifications provided by Member States.

The Panel considers that the claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.

“Skin health”

The claimed effect is “skin health”. The target population is assumed to be the general population.

The claimed effect is not sufficiently defined and no further details were given in the proposed wording or the clarifications provided by Member States.

The Panel considers that the claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.

Keywords
Lactobacillus johnsonii BFE 6128, skin, immune system, health claims
Print on demand
Number of Pages
13